Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2022 1
2024 6
2025 9
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Transplant outcomes in adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukaemia.
Aleid M, Fakih RE, Hanbali A, Alfraih F, Alothaimeen H, Elhassan T, Alahmari A, Rasheed W, Almohareb F, Chaudhri N, Alotaibi S, Alsharif F, Shaheen M, Alhayli S, Alkhaldi H, Alyamany R, Alshaibani A, Alotaibi AS, Alamer A, Albabtain AA, Ahmed SO, Alzahrani H, Aljurf M, Saad A, Alfayez M. Aleid M, et al. Among authors: alyamany r. Br J Haematol. 2026 Jan 25. doi: 10.1111/bjh.70347. Online ahead of print. Br J Haematol. 2026. PMID: 41582435 No abstract available.
Anticoagulants in hematologic malignancies: what is the data?
Alyamany R, Houghton DE. Alyamany R, et al. Hematology Am Soc Hematol Educ Program. 2025 Dec 5;2025(1):61-71. doi: 10.1182/hematology.2025000688. Hematology Am Soc Hematol Educ Program. 2025. PMID: 41348050 Free PMC article. Review.
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis.
Alyamany R, Alnughmush A, Remberger M, Law AD, Lam W, Kim DDH, Michelis FV, Pasic I, Novitzky-Basso I, Gerbitz A, Kumar R, Mattsson J, Viswabandya A. Alyamany R, et al. Br J Haematol. 2025 Dec;207(6):2507-2516. doi: 10.1111/bjh.70170. Epub 2025 Sep 18. Br J Haematol. 2025. PMID: 40968076
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD Prophylaxis.
Alnughmush A, Alyamany R, Remberger M, Pasic I, Novitzky-Basso I, Law AD, Lam W, Kim DDH, Michelis FV, Gerbitz A, Kumar R, Mattsson J, Viswabandya A. Alnughmush A, et al. Among authors: alyamany r. Eur J Haematol. 2025 Sep;115(3):251-259. doi: 10.1111/ejh.14438. Epub 2025 May 28. Eur J Haematol. 2025. PMID: 40437709 Free PMC article.
18 results